Algorithm predicts dialysis need in COVID patients upon admission

The novel coronavirus has shown a nasty penchant for targeting the kidneys, and physicians can’t always tell which patients will need dialysis until they do. By then it’s often too late to save a life.

A new machine learning model has proven accurate at making the call early enough to allow for advance planning, preparation and patient routing.

Lili Chan, MD, and colleagues at the Icahn School of Medicine at Mount Sinai described their work developing and testing the algorithm at a virtual national meeting of the American Society of Nephrology, which concluded over the weekend.

The team trained their model on data from more than 3,000 patients who were both hospitalized and COVID-positive. The researchers only included information gathered withing 48 hours of admission, challenging the AI to predict which patients with acute kidney injury would require dialysis.

In the test phase, the model delivered high accuracy (AUC of 0.79). The results showed the most valuable at-admission predictors to be blood levels of creatinine and potassium, age, and vital signs of heart rate and oxygen saturation.

“A machine learning model using admission features had good performance for prediction of dialysis need,” Chan says in a news release. “Models like this are potentially useful for resource allocation and planning during future COVID-19 surges. We are in the process of deploying this model into our healthcare systems to help clinicians better care for their patients.”

In another recent research project, Chan and colleagues found that, of nearly 4,000 COVID patients hospitalized in New York City, some 46% had acute kidney injury. Among these, 19% needed dialysis, and half of them died in the hospital.  

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

“Now more than ever, we must recognize that our country’s leadership in groundbreaking medical research spurs scientific innovation, improves public health and creates new innovations that save and improve lives nationwide,” Joseph C. Wu, MD, PhD, explained in a statement. 

The technology used to diagnose, treat and manage cardiovascular disease is always evolving, keeping FDA officials quite busy. But have the agency's standards been slipping in recent years? A cardiologist with Cedars-Sinai Medical Center explored that very question.

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”